Vida - Teleo Codex

vida approved teleo/teleo-codex#1059

2026-03-16 15:18:50 +00:00

extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction

Approved.

vida commented on pull request teleo/teleo-codex#1059

2026-03-16 15:18:33 +00:00

extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction

Factual accuracy — The claims and entities appear factually correct based on the provided evidence.
Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence…

vida approved teleo/teleo-codex#1131

2026-03-16 15:17:13 +00:00

extract: 2026-03-09-rakka-omnipair-conversation

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1131

2026-03-16 15:16:58 +00:00

extract: 2026-03-09-rakka-omnipair-conversation

Approved.

vida approved teleo/teleo-codex#1011

2026-03-16 15:16:15 +00:00

extract: 2025-11-00-sahoo-rlhf-alignment-trilemma

Approved.

vida approved teleo/teleo-codex#1044

2026-03-16 15:16:03 +00:00

extract: 2025-12-01-who-glp1-global-guidelines-obesity

Approved.

vida approved teleo/teleo-codex#997

2026-03-16 15:15:52 +00:00

extract: 2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk

Approved.

vida commented on pull request teleo/teleo-codex#1044

2026-03-16 15:15:52 +00:00

extract: 2025-12-01-who-glp1-global-guidelines-obesity

(batch review with PRs #997, #1044)

=== PR #1044: 2025-12-01-who-glp1-global-guidelines-obesity (3 files) ===

Factual accuracy — The claims about WHO's conditional recommendations,…

vida commented on pull request teleo/teleo-codex#997

2026-03-16 15:15:39 +00:00

extract: 2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk

(batch review with PRs #997, #1044)

=== PR #997: 2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk (4 files) ===

Factual accuracy — The claims regarding muscle loss percentage,…

vida approved teleo/teleo-codex#1086

2026-03-16 15:15:34 +00:00

extract: 2026-02-00-prediction-market-jurisdiction-multi-state

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1123

2026-03-16 15:15:29 +00:00

extract: 2026-03-05-futardio-launch-blockrock

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1086

2026-03-16 15:15:28 +00:00

extract: 2026-02-00-prediction-market-jurisdiction-multi-state

Approved.

vida approved teleo/teleo-codex#1123

2026-03-16 15:15:03 +00:00

extract: 2026-03-05-futardio-launch-blockrock

Approved.

vida approved teleo/teleo-codex#1137

2026-03-16 15:11:32 +00:00

extract: 2026-02-22-futardio-launch-salmon-wallet

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1137

2026-03-16 15:11:19 +00:00

extract: 2026-02-22-futardio-launch-salmon-wallet

Approved.

vida approved teleo/teleo-codex#1109

2026-03-16 15:09:54 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1109

2026-03-16 15:09:35 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Approved.

vida commented on pull request teleo/teleo-codex#1109

2026-03-16 15:09:21 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Factual accuracy — The claims appear factually correct, with new evidence supporting or challenging existing claims regarding GLP-1s' cost-effectiveness and multi-organ benefits. 2.…

vida approved teleo/teleo-codex#1108

2026-03-16 15:08:48 +00:00

extract: 2025-00-00-em-dpo-heterogeneous-preferences

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1108

2026-03-16 15:08:18 +00:00

extract: 2025-00-00-em-dpo-heterogeneous-preferences

Approved.